ARCHIVES

FDA Backs Down, Releases INDs, But Revives Controversy Over Clinical Testing Guidelines

This article is from The Cancer Letter archive.

Vol. 02 No. 11 | March 12, 1976

Download PDF Visit The Full Archive

Related Articles

Study Links Obesity To Higher Risk of Ovarian Cancer

January 30, 2009

Vince DeVita: Startup Funds For New Clinical Research Difficult To Get; Many Private Physicians More Capable Of Caring For Cancer Patients Than Those In Centers

July 16, 1976

FDA IND Approval Of New Cancer Drug Is First Based On Phase 1 Clinical Trials In Europe

December 5, 1986

NCAB Settles New Touchy PDQ Issues

June 7, 1985

NCI T BE More Flexible In Funding RFAs Above Paylines

June 23, 1989

Professional Societes; ASCO’s Strength Is In Its Diversify, Lichtor Says

May 21, 1999